Request Demo
Last update 30 Mar 2025
HY-07121
Last update 30 Mar 2025
Overview
Basic Info
Drug Type Antibody fusion proteins |
Synonyms HY-0007, HY07121 |
Target |
Action modulators, inhibitors |
Mechanism IL-15Rα modulators(Interleukin-15 receptor subunit alpha modulators), PDL1 inhibitors(Programmed death-ligand 1 inhibitors), TIGIT inhibitors(T cell immunoglobulin and ITIM domains inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
2
Clinical Trials associated with HY-07121NCT06639256
An Open-label, Multiple-center, Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Antitumor Activity of HY07121 Powder for Solution for Infusion in Patients With Advanced Solid Tumors
CTR20243657
一项评价注射用HY07121在晚期恶性实体瘤患者中的安全性、耐受性、药代动力学特征和初步临床有效性的多中心、开放的I/II期临床研究
[Translation] A multicenter, open-label Phase I/II clinical study to evaluate the safety, tolerability, pharmacokinetic characteristics and preliminary clinical efficacy of HY07121 for injection in patients with advanced malignant solid tumors
100 Clinical Results associated with HY-07121
Login to view more data
100 Translational Medicine associated with HY-07121
Login to view more data
100 Patents (Medical) associated with HY-07121
Login to view more data
100 Deals associated with HY-07121
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Advanced Malignant Solid Neoplasm | Phase 2 | China | 17 Oct 2024 | |
| Kidney Neoplasms | Preclinical | China | 01 Dec 2022 | |
| Melanoma | Preclinical | China | 01 Dec 2022 | |
| Non-Small Cell Lung Cancer | Preclinical | China | 01 Dec 2022 | |
| Ovarian Cancer | Preclinical | China | 01 Dec 2022 | |
| Small Cell Lung Cancer | Preclinical | China | 01 Dec 2022 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free